default author photo

Omar Rossi

GSK Vaccines Institute for Global Health

Avenue Fleming 20

Waver, 1300

Belgium

  • GSK Vaccines Institute for Global Health

SCHOLARLY PAPERS

6

DOWNLOADS

275

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Efficacy, Safety, and Immunogenicity of the Shigella sonnei 1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults

Number of pages: 33 Posted: 02 Mar 2021
Robert Frenck, Valentino Conti, Pietro Ferruzzi, Augustin GW Ndiaye, Susan Parker, Monica McNeal, Michelle Dickey, Juan-Paolo Granada, Giulia Luna Cilio, Iris De Ryck, Francesca Necchi, Akamol E. Suvarnapunya, Omar Rossi, Alessandra Acquaviva, Lakshmi Chandrasekaran, Kristen A. Clarkson, Joachim Auerbach, Elisa Marchetti, Robert W. Kaminski, Francesca Micoli, Rino Rappuoli, Allan Saul, Laura B. Martin and Audino Podda
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK, GSK, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, Fondazione Toscana Life Sciences - Monoclonal Antibody Discovery Lab (MAD), Burnet Institute, GSK Vaccines Institute for Global Health and GSK Vaccines Institute for Global Health
Downloads 122 (588,531)

Abstract:

Loading...

Shigella sonnei, 1790GAHB vaccine, GMMA, human challenge study, controlled human infection model, shigellosis

2.

Development and Qualification of a Multiplexed Immunoassay to Assess the Immunogenicity of Shigella Vaccines

Number of pages: 34 Posted: 24 Sep 2025
Paul W. Rhyne, Justine Sunshine, Wayne Hogrefe, Giulia Roscia, Eleonora Molesti, Alessandro Manenti, Claudia Semplici, Omar Rossi, Francesca Mancini, Francesca Micoli, Frank Medina, Robert W. Kaminski, Robert Noble, Cristina Alaimo, Stefanie Brighenti, Emanuele Montomoli and Nicole Frahm
Gates Medical Research Institute, Gates Medical Research Institute, Hogrefe Consulting, Inc., VisMederi SRL, VisMederi SRL, VisMederi SRL, VisMederi SRL, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, GSK Vaccines Institute for Global Health, Luminex Corporation, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, Gates Medical Research Institute, LimmaTech Biologics AG, LimmaTech Biologics AG, VisMederi SRL and Gates Medical Research Institute
Downloads 83 (783,685)

Abstract:

Loading...

Shigella, Lipopolysaccharide, Luminex, Immunoassay, Qualification

3.

Mucosal Immune Responses to Streptococcus pyogenes across the Life Course in a High Burden Setting: A Focus on Candidate Vaccine Antigens

Number of pages: 27 Posted: 02 Oct 2025
Fatoumata E. Camara, Alexander J. Keeley, Edwin Armitage, Gabrielle de Crombrugghe, Jainaba Sillah, Modou Lamin Fofana, Elina Senghore, Musukoi Jammeh, Alana L. Whitcombe, Amat Bittaye, Haddy Ceesay, Isatou Ceesay, Bunja Samateh, Muhammed Manneh, Adam J. Kucharski, Pierre Smeesters, Ya Jankey Jagne, Martina Carducci, Omar Rossi, Danilo Gomes Moriel, Beate Kampmann, Ed Clarke, Janessa Pickering, Nicole J. Moreland, Michael Marks, Henrik Salje, Claire Turner and Thushan I. de Silva
London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, Université Libre de Bruxelles (ULB) - Molecular Bacteriology Laboratory, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, University of Auckland - Faculty of Medical and Health Sciences, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, Université Libre de Bruxelles (ULB) - Molecular Bacteriology Laboratory, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, GlaxoSmithKline - Vaccines, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, London School of Hygiene & Tropical Medicine - Vaccines and Immunity Theme, The Kids Research Institute Australia, University of Auckland - Faculty of Medical and Health Sciences, London School of Hygiene & Tropical Medicine - Department of Clinical Research, University of Cambridge - Department of Genetics, University of Sheffield - School of Biosciences and University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease
Downloads 70 (875,328)

Abstract:

Loading...

Streptococcus pyogenes, Group A streptococcus, Oral fluid, Mucosal immunity, IgA

4.

Development of a Strep a Vaccine: Immuno/Safety Profile of an Adjuvanted Formulation with Alum

16TH VACCINE CONGRESS:P2.65
Posted: 19 Oct 2022
Francesco Citiulo, Emilia Cappelletti, Claudia Vitali, Martina Carducci, Luisa Massai, Luigi Sollai and Omar Rossi
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GlaxoSmithKline - Vaccines, affiliation not provided to SSRN, affiliation not provided to SSRN and GSK Vaccines Institute for Global Health

Abstract:

Loading...

5.

Strep a Vaccine: From Formulation Development to Toxicology Lot Production

16TH VACCINE CONGRESS:P2.58
Posted: 19 Oct 2022
Emilia Cappelletti, Xhenti Ferhati, Francesca Necchi, Danilo Gomes Moriel, Giulia Maria Massantini, Vittoria Marchetti, Antonia De Felice De Felice, Alessandra Acquaviva, Luca Rovetini, Federico Pippi, Filomena De Luca, Francesco Citiulo, Omar Rossi, Martina Carducci, Luisa Massai, Carlo Giannelli, Luigi Sollai, Giulia Iannello, Elena Fiorentini and Anna Maria Colucci
affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN

Abstract:

Loading...

6.

Manufacturing and Analytical Development of a Sustainable Vaccine Against Invasive Nontyphoidal Salmonellosis and Typhoid Fever

16TH VACCINE CONGRESS:P2.54
Posted: 19 Oct 2022
Antonia De Felice, Vittoria Marchetti, Emilia Cappelletti, Francesca Necchi, Federico Pippi, Maria Grazia Aruta, Francesco Citiulo, Alessandra Acquaviva, Luigi Sollai, Carlo Giannelli, Rocio Canals Alvarez, Omar Rossi, Francesco Berlanda Scorza and Anna Maria Colucci
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GSK Vaccines Institute for Global Health, affiliation not provided to SSRN and affiliation not provided to SSRN

Abstract:

Loading...